Currently, pharmacology offers us an incredibly huge selection of drugs. Pharmacy shelves are literally full of medicines for any ailments, but are they really able to solve health problems? And is the price consistent with quality? Servier's products are able to meet the needs of patients and doctors.
A bit of history
In the city of Orleans in France back in 1954, the company Servier was founded. The founder of the company is Dr. Jacques Servier. To this day, it is an independent leading pharmaceutical production. At first it was a small company consisting of only nine employees, and today it is a huge international-class pharmaceutical company that is known to five continents and more than 150 countries of the world. At the moment, the staff is more than 22 thousand people, including about three thousand scientists who are developing new technologies and drugs "Servier".
Servier in Russia
The friendship of a pharmaceutical company from France with Russia began in 1992. It was then that Servier drugs in Russia appeared on the shelves of pharmacies across the country. The company introduced original medicines for the treatment of chronic venous diseases, cardiovascular pathologies, diabetes mellitus, acute respiratory diseases and, of course, were used in such fields as oncology, rheumatology and neuropsychiatry.
After 5 years, Russian centers began to participate in international research with Servier, and in the early 00s, the Servier Clinical Research Center was opened in the Russian capital, where the main goal is the safety and efficacy of manufactured medicines for consumers. This leading international pharmaceutical company was one of the first in 2007 to establish its own manufacturing enterprise in the Russian Federation - a plant in the village of Sofyino. Due to the complete transfer of pharmaceutical production technologies , since 2009 Russia has switched to the full cycle of drug manufacturing in our country.
Pharmaceutical factory in Russia
Thanks to the opening of a full-cycle pharmaceutical plant that meets all the requirements of the international standard, Russia has entered a new stage and an innovative development path. This plant is the tenth production point of the Servier team industrial union, combining two chemical plants in Spain and France, as well as pharmaceutical companies in Spain, Egypt, France, China, Poland, Brazil, Morocco and Ireland. Dr. Jacques Servier, the founder of the company, takes care of her so much that even during the construction of the plant in the Podolsky district of Moscow, the general architectural style, features of the country's traditions and culture were observed. The pharmaceutical factory is the contribution of the Servier team to the implementation of the government's Pharma 2020 strategy and import substitution policy.
The list of drugs "Servier"
There are many medicines of this company. All Servier drugs are dispensed strictly according to a doctor’s prescription:
- "Arifon Retard" is prescribed for arterial hypertension.
- Arifam is also used for arterial hypertension who require amlodipine and indapamide therapy.
- In the treatment of infectious and inflammatory diseases of the respiratory tract, such as tracheitis, sinusitis, rhinitis and others, Bioparox will help you.
- The drug for the treatment of osteoporosis is Bivalos.
- Valdoxan is used to treat major depressive disorder in adults.
- The drug "Diabeton" is intended for the treatment of type 2 diabetes in adults.
- Detralex tablets and Detralex gel are used in cases of impaired venous circulation.
- "Coraxan" - therapy of stable angina with normal sinus rhythm and chronic heart failure.
- In depressive conditions, Coaxil will help.
- For malignant brain tumors - "Mustoforan".
- Antihypertensive drugs: Noliprel, Noliprel A, Noliprel A Forte, Noliprel A Bi-forte.
- Preductal is a Servier drug needed to prevent attacks of stable angina pectoris.
- The combined antianginal and antihypertensive drug is Prestans.
- Prevention of re-stroke, chronic heart failure, stable coronary heart disease - Prestarium A.
- "Pronoran" - used for Parkinson's disease.
- With overwork, decreased performance and weakness - "Enerion".
- "Erespal" in syrup or tablets is used for diseases of the upper and lower respiratory tract.
Priority areas of company development
The most important investments are:
- 27% of the total turnover goes to research and development of new drugs.
- The average share of turnover, which is 14%, is invested in research by ten world leaders in the pharmaceutical industry.
- 9% invest in scientific activity.
As employees of "Servier" say: "The activity of our company is based on scientific research, it is directed to the future."